Nadja Vuori, Niina Sandholm, Anmol Kumar, Kustaa Hietala, Anna Syreeni, Carol Forsblom, Kati Juuti-Uusitalo, Heli Skottman, Minako Imamura, Shiro Maeda, Paula A. Summanen, Markku Lehto,Per-Henrik Groop; on behalf of the FinnDiane Study

Päivärinta J, Oikonen V, Räisänen-Sokolowski A, Tolvanen T, Löyttyniemi E, Iida H, Nuutila P, Metsärinne K, Koivuviita N

Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, O'Donnell M, Fox KAA, Bhatt DL, Cairns JA, Tasto C9, Berkowitz SD, Cook Bruns N, Muehlhofer E, Diaz R, Maggioni AP, Yusuf S.

Emma H Dahlström, Niina Sandholm, Carol M Forsblom, Lena M Thorn, Fanny J Jansson, Valma Harjutsalo, Per-Henrik Groop; on behalf of the FinnDiane Study Group

Branch KR, Probstfield JL, Eikelboom JW, Bosch J, Maggioni AP, Cheng RK, Bhatt DL, Avezum A, Fox KAA, Connolly SJ, Shestakovska O, Yusuf S.

de Vries, Eikelboom JW, Bosch J, Westerink J, Dorresteijn JAN, Alings M, Dyal L, Berkowitz SD, van der Graaf Y, Fox KAA, Visseren FLJ.

Markus Hakamäki, Kaj Metsärinne

Fox K.A.A., Eikelboom J.W., Shestakovska O., Connolly S.J., Metsärinne K.P., Yusuf S.

Colombo M, Valo E, McGurnaghan SJ, Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue PM, Forsblom C, Colhoun HM; FinnDiane Study Group and the Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Collaboration

John W. Eikelboom, MBBS, Stuart J. Connolly, MD, Jacqueline Bosch, PhD, Olga Shestakovska, MSc, Victor Aboyans, MD, Marco Alings, MD, Sonia S. Anand, MD, Alvaro Avezum, MD, PhD, Scott D. Berkowitz, MD, Deepak L. Bhatt, MD, Nancy Cook-Bruns, MD, Camilo Felix, MD, Keith A.A. Fox, MBChB, Robert G. Hart, MD, Aldo P. Maggioni, MD, Paul Moayyedi, MD, Martin O’Donnell, MB, Lars Rydén, MD, Peter Verhamme, MD, Petr Widimsky, MD, Jun Zhu, MD, and Salim Yusuf, MBBS, COMPASS Research Group